It is hence possible that PGE2 potentiates IL-23-mediated intestinal inflammation through enhancing EP4-dependent pathogenic CD4+RORγt+ responses, while in other instances and locations (like the mLN) it can induce CD4+FoxP3+ cells that protect from colitis development. The gene discussed is PTGER4; the disease is colitis.